Since the de novo lipogenesis rate is higher in human NAFLD than that of normal subjects [49], our results suggest down-regulation of the CDK8-CycC complex by mTORC1 as an important contributing factor to the observed increase of hepatic de novo lipogenesis in NAFLD and insulin resistant states. Here, CCNC is linked to metabolic dysfunction-associated steatotic liver disease.